* Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.’s Google DeepMind (GOOG [https://seekingalpha.com/symbol/GOOG]) (GOOG [https://seekingalpha.com/symbol/GOOG]), is in early talks to raise new funds at a valuation of at least $40B, according to _Bloomberg_. * The round could value Isomorphic as highly as $50B, one of the sources said. The financing hasn’t closed, and details could change, as per the report. * Only five months ago, Isomorphic Labs raised $2.1B in its Series B funding effort. * Separately, the US government and tech giants Meta Platforms (META [https://seekingalpha.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.